Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Variant BDNF Val66Met polymorphism affects extinction of conditioned aversive memory.

Brain-derived neurotrophic factor (BDNF) plays important roles in activity-dependent plasticity processes, such as long-term potentiation, learning, and memory. The recently reported human BDNF Val66Met (BDNF(Met)) polymorphism has been shown to lead to altered hippocampal volume and impaired hippocampal-dependent memory and is associated with a variety of neuropsychiatric disorders. There are few studies, however, that investigate the effect of the BDNF(Met) polymorphism on hippocampal-independent memory processes. A conditioned taste aversion (CTA) task was used for studying the mechanisms of long-term, hippocampal-independent, nondeclarative memory in the mammalian brain. Using the CTA paradigm, we found a novel impairment in extinction learning, but not acquisition or retention, of aversive memories resulting from the variant BDNF(Met). BDNF(Met) mice were slower to extinguish an aversive CTA memory compared with wild-type counterparts. Moreover, the BDNF(Met) was associated with smaller volume and decreased neuronal dendritic complexity in the ventromedial prefrontal cortex (vmPFC), which plays a significant role in extinction of CTA. Finally, this delay in extinction learning could be rescued pharmacologically with a cognitive enhancer, d-cycloserine (DCS). To our knowledge, this is the first evidence that the BDNF(Met) polymorphism contributes to abnormalities in memory extinction. This abnormality in extinction learning may be explained by alterations in neuronal morphology, as well as decreased neural activity in the vmPFC. Importantly, DCS was effective in rescuing this delay in extinction, suggesting that when coupled with behavior therapy, DCS may be an effective treatment option for anxiety disorders in humans with this genetic variant BDNF.

Pubmed ID: 19339601 RIS Download

Mesh terms: Animals | Avoidance Learning | Behavior, Animal | Brain | Brain-Derived Neurotrophic Factor | Cycloserine | Extinction, Psychological | Food Preferences | Lithium Chloride | Male | Memory | Methionine | Mice | Mice, Transgenic | Polymorphism, Genetic | Proto-Oncogene Proteins c-fos | Silver Staining | Taste | Time Factors | Valine

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIMH NIH HHS, Id: MH079513
  • Agency: NIMH NIH HHS, Id: P50 MH079513-01A10001
  • Agency: NIMH NIH HHS, Id: P50 MH079513
  • Agency: NINDS NIH HHS, Id: R01 NS052819-04
  • Agency: NINDS NIH HHS, Id: R01 NS052819
  • Agency: NIMH NIH HHS, Id: MH068850
  • Agency: NIMH NIH HHS, Id: K08 MH068850
  • Agency: NIMH NIH HHS, Id: MH060478
  • Agency: NINDS NIH HHS, Id: NS052819
  • Agency: NIMH NIH HHS, Id: R25 MH060478

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.